Nachrichten zur Hims & Hers Health Inc. Aktie

On June 22, 2026, Hims & Hers Health Inc (HIMS) shares fell 5.4% today, trading at $33.54. Over the past…

Hims & Hers Health (HIMS, i) ist mit einer Leerverkaufsquote von rund 28,4 % eines der meist geshorteten Mid Caps…

US digital health provider Hims & Hers Health has acquired Eucalyptus, the parent company of Juniper, to expand its preventative…

?Chief Medical Officer Patrick Carroll filed to sell up to 23,726 shares worth about $830K on Thursday. ?HIMS stock is…

Hims & Hers Health, Inc. built one of the fastest-growing telehealth businesses in the country, only to watch regulators dismantle…

NEW YORK CITY, NY / ACCESS Newswire / June 21, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential…

In recent weeks, Hims & Hers Health has secured a partnership with Novo Nordisk to offer GLP-1 weight-loss drugs, completed…

Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine…

Explore more price target data and ratings for Hims & Hers Health, Inc. on the Forecasts tab, and track all…

On June 18, 2026, Hims & Hers Health Inc (HIMS) shares rose 11.2% to a current price of $35.47. This…

On June 18, 2026, recent trading activity for Hims and Hers Health Inc (HIMS) has shown a significant bullish trend,…

Hims & Hers Health (NYSE: HIMS) shares are climbing after Barclays reiterated its bullish stance and lifted its price target…

Are hedge funds shorting Hims & Hers Health (NYSE:HIMS) stock? View the latest HIMS short interest ratio, short volume, and…

London (www.aktiencheck.de) - Hims & Hers-Aktienanalyse von Barclays:Barclays habe das Kursziel für die Aktie von Hims & Hers Health Inc.…

Hims & Hers Health (HIMS) is up 6.7% today. Here is some analysis on what might have caused this price…

Hims & Hers Health surged 7.0% on Thursday to $34.11 per share as bullish analyst commentary reinforced the telemedicine companys…

Why is Hims & Hers Health stock surging today?…

Why is Hims & Hers Health stock surging today?…

Hims & Hers leverages a Novo Nordisk partnership and cross-selling to counter weak first-quarter metrics. Find out why HIMS stock…

Hims & Hers Health pivots to branded GLP-1 products, with it already driving robust engagement/subscriber growth. Read why HIMS stock…

Dear reader, in only a few years, an American startup evolved from a simple platform selling hair-loss treatments into one…

Hims & Hers COO Michael Chi sells $441,850 in company stock…

Hims & Hers PAO Irene Becklund sells $370,518 in stock…

Hims & Hers Chief Medical Officer Patrick Harrison reported RSU vesting into 25,926 Class A shares, with 8,310 shares withheld…